Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4556110015 | Trientine tetrahydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4556111016 | Trientine tetrahydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trientine tetrahydrochloride | Is modification of | Trientine | true | Inferred relationship | Existential restriction modifier | ||
| Trientine tetrahydrochloride | Has disposition | Chelating agent | true | Inferred relationship | Existential restriction modifier | ||
| Trientine tetrahydrochloride | Is a | Substance with chelating agent mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Trientine tetrahydrochloride | Is a | Ethylenediamine and/or ethylenediamine derivative | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely trientine (as trientine tetrahydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Trientine tetrahydrochloride | Inferred relationship | Existential restriction modifier | 1 |
| Trientine 150mg tablets | Has specific active ingredient | True | Trientine tetrahydrochloride | Inferred relationship | Existential restriction modifier | |
| Cuprior 150mg tablets (Orphalan UK Ltd) | Has specific active ingredient | True | Trientine tetrahydrochloride | Inferred relationship | Existential restriction modifier | |
| Trientine 150mg tablets 72 tablet | Has specific active ingredient | True | Trientine tetrahydrochloride | Inferred relationship | Existential restriction modifier | |
| Cuprior 150mg tablets (Orphalan UK Ltd) 72 tablet 9 x 8 tablets | Has specific active ingredient | True | Trientine tetrahydrochloride | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR